Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,098 products)
- Organic Building Blocks(61,059 products)
Found 199580 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
2-tert-Butyl-5-(methylsulfanyl)-1,3,4-oxadiazole
CAS:Versatile small molecule scaffoldFormula:C7H12N2OSPurity:Min. 95%Molecular weight:172.2 g/mol2-(4-tert-Butyl-1H-pyrazol-1-yl)phenol
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H16N2OPurity:Min. 95%Molecular weight:216.28 g/mol3-Methyl-[1,2]oxazolo[5,4-c]pyridine
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H6N2OPurity:Min. 95%Molecular weight:134.14 g/mol3-Amino-4-hydroxy-6-methyl-2H-pyran-2-one
CAS:3-Amino-4-hydroxy-6-methyl-2H-pyran-2-one is a metabotropic glutamate receptor ligand that has a chemical structure similar to 7-amino-4,7 -dimethylcoumarin. It binds to the metabotropic glutamate receptor and blocks the binding of glutamate in synapses, inhibiting its normal activity. 3AAMC is an allosteric modulator of the metabotropic glutamate receptor because it binds at a site different from that which binds glutamate. This type of modulation leads to changes in the sensitivity of the receptor to other ligands such as AMPA. 3AAMC also inhibits amine uptake and dielectrophile alkylation by chloride ions, which may lead to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.Formula:C6H7NO3Purity:Min. 95%Molecular weight:141.12 g/mol2-(N-Methyl-2-aminobenzamido)benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C15H14N2O3Purity:Min. 95%Molecular weight:270.28 g/mol1-Benzyl-1,2-dihydropyridin-2-imine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C12H13ClN2Purity:Min. 95%Molecular weight:220.7 g/mol3-Bromo-2-methyl-furan
CAS:<p>3-Bromo-2-methyl-furan is a substituted quinoline. It is a synthetic reagent that can be used for the synthesis of bromofuran derivatives. The methyl group on the 3rd carbon atom in 3-bromo-2-methyl-furan is a substituent that can be exchanged with other substituents, such as alkylation, to produce a variety of products.<br>3-Bromo-2-methyl furan has been shown to be able to extract metal ions from their complexes and form stable complexes. This property makes it an ideal reagent for metalation reactions.</p>Formula:C5H5BrOPurity:Min. 95%Molecular weight:161 g/mol2-(3,5-Dimethyl-1H-pyrazol-4-yl)ethan-1-ol
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H12N2OPurity:Min. 95%Molecular weight:140.18 g/mol5-chloro-3-methylimidazo[4,5-b]pyridine
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H6N3ClPurity:Min. 95%Molecular weight:167.59 g/mol2-Chloro-N-(2-methyl-4-nitro-phenyl)-acetamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H9ClN2O3Purity:Min. 95%Molecular weight:228.6 g/mol2-(2,2-Dimethylpropoxy)acetic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H14O3Purity:Min. 95%Molecular weight:146.18 g/molBis(2,2,2-trifluoroethoxy)methanethione
CAS:Versatile small molecule scaffoldFormula:C5H4F6O2SPurity:Min. 95%Molecular weight:242.14 g/mol1-Methoxycarbonylpyrrolidin-3-ol
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H11NO3Purity:Min. 95%Molecular weight:145.16 g/mol2-Iodo-N-methylacetamide
CAS:2-Iodo-N-methylacetamide is a vasotocin analogue that is used as a research tool to study the interaction of arginine vasotocin in the pancreas. 2-Iodo-N-methylacetamide has been shown to inhibit pancreatic enzyme activity and intestinal absorption of glucose, while enhancing insulin release. This drug also binds to the beta cells of the pancreas, inhibiting melatonin synthesis and increasing bovine serum albumin (BSA) hydroxyindoleacetic acid (HIAA) levels. The effects are reproducible in rats, with 2-iodo-N-methylacetamide binding to glutamic acid decarboxylase and inhibiting HIAA synthesis in vitro.Formula:C3H6INOPurity:Min. 95%Molecular weight:198.99 g/mol1,4-Dimethoxy-5,6,7,8-tetrahydronaphthalene-2-carbaldehyde
CAS:Versatile small molecule scaffoldFormula:C13H16O3Purity:Min. 95%Molecular weight:220.3 g/mol2-(2,2-Dimethylmorpholino)ethanol
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H17NO2Purity:Min. 95%Molecular weight:159.23 g/mol1-Chlorocyclohexane-1-carbonitrile
CAS:Versatile small molecule scaffoldFormula:C7H10ClNPurity:Min. 95%Molecular weight:143.61 g/mol6-Ethyl-2-phenyl-3,4-dihydropyrimidin-4-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H12N2OPurity:Min. 95%Molecular weight:200.24 g/mol1-Methyl-3,4-dihydro-1H-2-benzopyran-1-carbaldehyde
CAS:Versatile small molecule scaffoldFormula:C11H12O2Purity:Min. 95%Molecular weight:176.21 g/mol3-Benzyl-3-azabicyclo[3.2.1]octan-8-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H17NOPurity:Min. 95%Molecular weight:215.3 g/mol
